Adaptor Protein-3 Produces Synaptic Vesicles that Release Phasic Dopamine.
Biological Sciences
Neuroscience
VPS41
adaptor protein-3 (AP-3)
phasic dopamine
reinforcement learning
synaptic vesicles
vesicular monoamine transporter 2 (VMAT2)
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
08 Aug 2023
08 Aug 2023
Historique:
pubmed:
23
8
2023
medline:
23
8
2023
entrez:
23
8
2023
Statut:
epublish
Résumé
The burst firing of midbrain dopamine neurons releases a phasic dopamine signal that mediates reinforcement learning. At many synapses, however, high firing rates deplete synaptic vesicles (SVs), resulting in synaptic depression that limits release. What accounts for the increased release of dopamine by stimulation at high frequency? We find that adaptor protein-3 (AP-3) and its coat protein VPS41 promote axonal dopamine release by targeting vesicular monoamine transporter VMAT2 to the axon rather than dendrites. AP-3 and VPS41 also produce SVs that respond preferentially to high frequency stimulation, independent of their role in axonal polarity. In addition, conditional inactivation of VPS41 in dopamine neurons impairs reinforcement learning, and this involves a defect in the frequency dependence of release rather than the amount of dopamine released. Thus, AP-3 and VPS41 promote the axonal polarity of dopamine release but enable learning by producing a novel population of SVs tuned specifically to high firing frequency that confers the phasic release of dopamine.
Identifiants
pubmed: 37609166
doi: 10.1101/2023.08.07.552338
pmc: PMC10441354
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NIDA NIH HHS
ID : F32 DA051135
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA035821
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS095809
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS103938
Pays : United States
Commentaires et corrections
Type : UpdateIn
Déclaration de conflit d'intérêts
Competing interests: RHE is a consultant for Nine Square Therapeutics. The authors declare that they have no other competing interests.